AcedrA Pharmaceutical Company

http://www.acedrarx.com/

Industry

Pharmaceuticals
- Specialty Pharmaceuticals

Other Names/Subsidiaries

AcedrA BioPharmaceuticals

See more in Biomedtracker

Latest on AcedrA Pharmaceutical Company

Scrip

Asia Deal Watch: Nippon Shinyaku Takes On Intractable Rare Disease With MiNA

11 Apr 2024

• By Joseph Haas, Dexter Jie Yan, Vibha Ravi, Lisa Takagi, and Anju Ghangurde

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. MiNA Will Provide RNAa Candidates

Scrip

Deal Watch: Gilead Acquires Xilio’s IL-12 Activating Candidate

29 Mar 2024

• By Joseph Haas and Alaric DeArment

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Gets Xilio’s Phase I Cancer Drug

Already A Biomedtracker Subscriber?You have access to the full company record through your subscription.

Go To Biomedtracker

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Home

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.